Organogenesis Holdings Inc.
ORGO
$5.05
$0.030.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 150.49M | 100.78M | 86.69M | 126.66M | 115.18M |
| Total Other Revenue | 377.00K | 226.00K | -- | -- | -- |
| Total Revenue | 150.86M | 101.01M | 86.69M | 126.66M | 115.18M |
| Cost of Revenue | 36.25M | 27.63M | 23.72M | 31.05M | 26.80M |
| Gross Profit | 114.61M | 73.38M | 62.97M | 95.61M | 88.38M |
| SG&A Expenses | 79.23M | 73.81M | 72.51M | 73.86M | 71.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.70M | 111.84M | 106.87M | 116.44M | 108.94M |
| Operating Income | 22.17M | -10.83M | -20.18M | 10.22M | 6.24M |
| Income Before Tax | 21.16M | -11.83M | -25.78M | 10.25M | 5.82M |
| Income Tax Expenses | -407.00K | -2.44M | -6.94M | 2.58M | -6.51M |
| Earnings from Continuing Operations | 21.57M | -9.39M | -18.84M | 7.67M | 12.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.57M | -9.39M | -18.84M | 7.67M | 12.33M |
| EBIT | 22.17M | -10.83M | -20.18M | 10.22M | 6.24M |
| EBITDA | 27.04M | -6.26M | -15.89M | 14.67M | 10.65M |
| EPS Basic | 0.11 | -0.06 | -0.17 | 0.05 | 0.09 |
| Normalized Basic EPS | 0.11 | -0.05 | -0.10 | 0.05 | 0.03 |
| EPS Diluted | 0.11 | -0.06 | -0.17 | 0.04 | 0.09 |
| Normalized Diluted EPS | 0.11 | -0.05 | -0.10 | 0.05 | 0.03 |
| Average Basic Shares Outstanding | 126.88M | 126.86M | 126.30M | 129.68M | 132.58M |
| Average Diluted Shares Outstanding | 130.85M | 126.86M | 126.30M | 132.16M | 133.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |